Resultados globales: 2 registros encontrados en 0.04 segundos.
Artículos, Encontrados 2 registros
Artículos Encontrados 2 registros  
1.
15 p, 678.4 KB Health technology assessment for the acute and preventive treatment of migraine : A position statement of the International Headache Society / Diener, Hans-Christoph (Institute for Medical Informatics, Biometry and Epidemiology, University Duisburg-Essen, Essen, Berlin, Germany) ; Ashina, Messoud (University of Copenhagen) ; Durand-Zaleski, Isabelle (Santé Publique Hôpital Henri Mondor, Créteil, France) ; Kurth, Tobias (Charité - Universitätsmedizin Berlin) ; Lantéri-Minet, Michel (Départment d'Evaluation et Traitement de la Douleur, CHU de Nice, FHU InovPain, Universite Cete Azur, Nice, France) ; Lipton, Richard B. (Albert Einstein College of Medicine) ; Ollendorf, Daniel A. (Value Measurement and Global Health Initiatives, Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, , Boston, MA, USA) ; Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Tassorelli, Cristina (Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy) ; Terwindt, Gisela (Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands) ; Universitat Autònoma de Barcelona
The Clinical Trials Subcommittee of the International Headache Society presents the first Health Technology Assessment for the Acute Treatment of Migraine Attacks and Prevention of Migraine. Health technology assessments are systematic evaluations of the properties, effects, and consequences of healthcare technologies; this position statement is designed to inform decision makers about access to and reimbursement for medications and devices for the acute and preventive treatment of migraine. [...]
2021 - 10.1177/0333102421989247
Cephalalgia, Vol. 41 (january 2021) , p. 279-293  
2.
9 p, 267.6 KB Therapeutic hypothermia for acute ischaemic stroke. Results of a European multicentre, randomised, phase III clinical trial / van der Worp, H. B. (Department of Neurology and Neurosurgery. Brain Center. University Medical Center Utrecht) ; Macleod, Malcolm R. (Centre for Clinical Brain Sciences. University of Edinburgh) ; Bath, P. M. W. (Stroke Trials Unit. Division of Clinical Neuroscience. University of Nottingham) ; Bathula, R. (Stroke Department. Northwick Park Hospital) ; Christensen, Hanne (University of Copenhagen) ; Colam, B. (Centre for Clinical Brain Sciences. University of Edinburgh) ; Cordonnier, Charlotte (University of Lille. Inserm U1171. Degenerative and Vascular Cognitive Disorders. Centre Hospitalier Universitaire Lille) ; Demotes-Mainard, J. (ECRIN) ; Durand-Zaleski, I. (APHP URCEco. University Paris Est Creteil & INSERM. UMR 1123) ; Gluud, C. (Copenhagen Trial Unit. Centre for Clinical Intervention Research. Rigshospitalet. Copenhagen University Hospital) ; Jakobsen, J. C. (Holbæk Hospital (Dinamarca)) ; Kallmünzer, B. (Department of Neurology. University Medical Centre Erlangen) ; Kollmar, R. (Klinik für Neurologie und Neurointensivmedizin. Klinikum Darmstadt) ; Krieger, D. W. (Mediclinic Middle East) ; Lees, K. R. (School of Medicine. Dentistry & Nursing. University of Glasgow) ; Michalski, D. (Department of Neurology. University of Leipzig) ; Molina, Carlos (Hospital Universitari Vall d'Hebron) ; Montaner, Joan (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Roine, R. O. (Turku University Hospital (Finlàndia)) ; Petersson, J. (Skåne University Hospital (Suècia)) ; Perry, Richard (Stroke Service. National Hospital for Neurology & Neurosurgery) ; Sprigg, N. (Stroke Trials Unit. Division of Clinical Neuroscience. University of Nottingham) ; Staykov, D. (Department of Neurology. Hospital of the Brothers of St. John) ; Szabo, I. (European Stroke Research Network for Hypothermia) ; Vanhooren, G. (AZ Sint-Jan Brugge-Oostende) ; Wardlaw, J. M. (Edinburgh Imaging. Centre for Clinical Brain Sciences. UK Dementia Research Institute. University of Edinburgh) ; Winkel, P. (Copenhagen Trial Unit. Centre for Clinical Intervention Research. Rigshospitalet. Copenhagen University Hospital) ; Schwab, S. (Department of Neurology. University Medical Centre Erlangen) ; Universitat Autònoma de Barcelona
Introduction: We assessed whether modest systemic cooling started within 6 hours of symptom onset improves functional outcome at three months in awake patients with acute ischaemic stroke. Patients and methods: In this European randomised open-label clinical trial with blinded outcome assessment, adult patients with acute ischaemic stroke were randomised to cooling to a target body temperature of 34. [...]
2019 - 10.1177/2396987319844690
European Stroke Journal, Vol. 4 Núm. 3 (january 2019) , p. 254-262  

Vea también: autores con nombres similares
1 Durand-Zaleski, Isabelle
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.